Search

for
Search:

Glossary Off-label Use

prescribing medication for an unapproved condition or dosage

Off-label use refers to the practice of prescribing a medication for a purpose that has not been officially approved by regulatory agencies like the FDA. This can include using the drug to treat a different condition, in a different dosage, or in a different patient population than what is specified in the approved labeling. While off-label use is legal and can be based on sound medical evidence, it often requires careful consideration and professional judgment.

Related Terms

Research

5 / 1000+ results

research Off-Label Use of Topical Minoxidil in Alopecia: A Review

32 citations , January 2019 in “American Journal of Clinical Dermatology”

This review discusses the use of topical minoxidil for various types of alopecia and reports mixed evidence on its efficacy, with stronger support noted for conditions like eyebrow hypotrichosis and chemotherapy-induced alopecia.

research Off-Label Uses of Topical Vitamin D in Dermatology: A Systematic Review

26 citations , March 2014 in “Journal of cutaneous medicine and surgery”

This study provides evidence-based recommendations for the off-label use of topical vitamin D in treating certain skin conditions, but highlights the need for higher quality studies for further validation.

research Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis

10 citations , September 2024 in “Life”

This review found that, among 103 patients treated off-label with abrocitinib for conditions beyond atopic dermatitis, favorable clinical outcomes were reported for most cases, except one isolated case involving erythematotelangiectatic rosacea.

research Off-label uses of retinoids in dermatology

6 citations , September 2012 in “Our Dermatology Online”

This review discusses the off-label uses of retinoids in dermatology, focusing on oral isotretinoin and acitretin, and reports no new clinical results.

research Off-Label Use of Botulinum Toxin in Dermatology—Current State of the Art

5 citations , May 2022 in “Molecules”

This article reviews the literature on the off-label use of botulinum toxin for dermatological conditions, highlighting its potential effectiveness in treating rosacea, anal fissures, Raynaud phenomenon, hypertrophic scars, keloids, and hidradenitis suppurativa.

View more "off-label use" in research →

Community Join

5 / 1000+ results

community Anyone found Clascoterone (5%) off-label at UK or EU pharmacies?

6 upvotes 3 months ago

The conversation is about hair loss treatments, specifically discussing Clascoterone (5%) availability in UK or EU pharmacies. Users also mention pyrilutamide and its availability from Kintor as a cosmetic.

community Do you think most celebrities use Dutasteride instead of Finasteride?

in Finasteride/Dutasteride 58 upvotes 4 months ago

Celebrities may use Dutasteride for hair loss, but Finasteride is more commonly used due to its extensive research and long-term safety. Dutasteride is considered more effective but is often used off-label or as a secondary option.

community Would you still need to be on finasteride if Verteporfin becomes widely used?

25 upvotes 2 years ago

The conversation discusses whether finasteride would still be necessary if Verteporfin becomes a successful hair loss treatment. It also explores the sensitivity of transplanted hair to DHT and the potential for off-label use of Verteporfin post hair transplant.

community Finasteride for women?

3 upvotes 7 years ago

Finasteride is sometimes used off-label for women with hair loss, but spironolactone is often recommended first. Minoxidil and estrogen supplements are also mentioned as treatments.

community My brain absorbing the assorted off label drugs I put near it on a daily basis just for maximum keratin production

23 upvotes 1 year ago

The conversation humorously discusses using off-label drugs like Minoxidil, finasteride, and RU58841 for hair growth. It jokes about the brain absorbing these treatments for maximum keratin production.

View more "off-label use" in community →

Learn

7 / 801 results

learn Tofacitinib

What types of hair loss conditions are most commonly associated with tofacitinib use in clinical settings? Published studies link tofacitinib mainly to alopecia areata and its severe variants — as an off-label drug being studied for them, not as a cause of hair loss. The evidence is mostly small, open-label or retrospective, and relapse after stopping is commonly reported.

learn Spironolactone

How does spironolactone help reduce hair loss when used in topical or oral treatments? Studies report that spironolactone slows androgen-driven follicle miniaturisation by blocking androgen receptors, with most evidence in women and mostly alongside minoxidil; it is a prescription drug and its use for hair loss is off-label.

learn Rapamycin

Is rapamycin safe for long-term use on the scalp, or should it be used in cycles? There is no published human trial of topical rapamycin on the scalp, so nobody knows whether long-term use is safe; the idea of cycling it comes from community practice and theory, not from any study or guideline, and rapamycin for hair loss is an off-label use of a prescription immunosuppressant.

learn Cetirizine

Is topical cetirizine effective for androgenetic alopecia in women? Topical cetirizine is not an approved product and its use for female-pattern hair loss is off-label. The evidence is one small unblinded pilot study in mixed-sex patients and one randomized trial in 66 women where cetirizine was added to minoxidil; it is unproven on its own.

learn Botox

How many Botox sessions are needed to see hair regrowth? Studies used Botox sessions months apart, not every six weeks. Botox is off-label for hair loss and must be prescribed and injected by a doctor.

learn Dutasteride

Heavy duty finasteride that comes with higher risks

learn Overview

View more "off-label use" in learn →

Clinics

6 / 13 results

All 13 clinic results →

Experts

— no results

Try a deeper search in experts →